Aull & Monroe Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.44M | Buy |
9,494
+50
| +0.5% | +$17.1K | 1.44% | 22 |
|
|
2026
Q1 | $3.32M | Hold |
9,444
| – | – | 1.54% | 20 |
|
|
2025
Q4 | $3.09M | Sell |
9,444
-1
| -0% | -$317 | 1.55% | 21 |
|
|
2025
Q3 | $2.67M | Buy |
9,445
+161
| +2% | +$46.7K | 1.36% | 27 |
|
|
2025
Q2 | $2.59M | Sell |
9,284
-1,130
| -11% | -$320K | 1.39% | 25 |
|
|
2025
Q1 | $3.24M | Sell |
10,414
-100
| -1% | -$29.5K | 1.61% | 22 |
|
|
2024
Q4 | $2.74M | Sell |
10,514
-490
| -4% | -$145K | 1.4% | 22 |
|
|
2024
Q3 | $3.55M | Sell |
11,004
-311
| -3% | -$102K | 1.64% | 20 |
|
|
2024
Q2 | $3.54M | Sell |
11,315
-675
| -6% | -$198K | 1.73% | 17 |
|
|
2024
Q1 | $3.41M | Sell |
11,990
-450
| -4% | -$132K | 1.56% | 23 |
|
|
2023
Q4 | $3.58M | Sell |
12,440
-224
| -2% | -$61K | 1.77% | 18 |
|
|
2023
Q3 | $3.4M | Sell |
12,664
-150
| -1% | -$37.4K | 1.78% | 18 |
|
|
2023
Q2 | $2.84M | Hold |
12,814
| – | – | 1.43% | 21 |
|
|
2023
Q1 | $3.1M | Sell |
12,814
-200
| -2% | -$49.1K | 1.58% | 19 |
|
|
2022
Q4 | $3.42M | Sell |
13,014
-490
| -4% | -$131K | 1.7% | 19 |
|
|
2022
Q3 | $3.04M | Hold |
13,504
| – | – | 1.67% | 20 |
|
|
2022
Q2 | $3.29M | Sell |
13,504
-110
| -0.8% | -$27K | 1.66% | 21 |
|
|
2022
Q1 | $3.29M | Buy |
13,614
+200
| +1% | +$46K | 1.48% | 23 |
|
|
2021
Q4 | $3.02M | Sell |
13,414
-250
| -2% | -$52.8K | 1.35% | 28 |
|
|
2021
Q3 | $2.9M | Sell |
13,664
-52
| -0.4% | -$12K | 1.43% | 24 |
|
|
2021
Q2 | $3.34M | Hold |
13,716
| – | – | 1.59% | 17 |
|
|
2021
Q1 | $3.41M | Sell |
13,716
-285
| -2% | -$68K | 1.66% | 16 |
|
|
2020
Q4 | $3.22M | Buy |
14,001
+296
| +2% | +$68.2K | 1.71% | 16 |
|
|
2020
Q3 | $3.48M | Hold |
13,705
| – | – | 2.05% | 13 |
|
|
2020
Q2 | $3.23M | Sell |
13,705
-700
| -5% | -$160K | 2% | 15 |
|
|
2020
Q1 | $2.92M | Buy |
14,405
+75
| +0.5% | +$16.4K | 1.96% | 14 |
|
|
2019
Q4 | $3.46M | Sell |
14,330
-100
| -0.7% | -$22K | 1.75% | 16 |
|
|
2019
Q3 | $2.79M | Sell |
14,430
-50
| -0.3% | -$9.6K | 1.48% | 20 |
|
|
2019
Q2 | $2.67M | Buy |
14,480
+555
| +4% | +$99.4K | 1.42% | 21 |
|
|
2019
Q1 | $2.65M | Sell |
13,925
-800
| -5% | -$153K | 1.42% | 20 |
|
|
2018
Q4 | $2.87M | Sell |
14,725
-582
| -4% | -$114K | 1.64% | 19 |
|
|
2018
Q3 | $3.17M | Sell |
15,307
-25
| -0.2% | -$4.93K | 1.53% | 18 |
|
|
2018
Q2 | $2.83M | Buy |
15,332
+2,075
| +16% | +$367K | 1.45% | 19 |
|
|
2018
Q1 | $2.26M | Hold |
13,257
| – | – | 1.18% | 28 |
|
|
2017
Q4 | $2.31M | Sell |
13,257
-400
| -3% | -$70.8K | 1.16% | 29 |
|
|
2017
Q3 | $2.55M | Sell |
13,657
-150
| -1% | -$26.6K | 1.31% | 24 |
|
|
2017
Q2 | $2.38M | Hold |
13,807
| – | – | 1.27% | 25 |
|
|
2017
Q1 | $2.27M | Sell |
13,807
-217
| -2% | -$36.1K | 1.21% | 25 |
|
|
2016
Q4 | $2.05M | Buy |
14,024
+75
| +0.5% | +$11.3K | 1.15% | 29 |
|
|
2016
Q3 | $2.33M | Buy |
13,949
+100
| +0.7% | +$16.9K | 1.34% | 25 |
|
|
2016
Q2 | $2.11M | Buy |
13,849
+32
| +0.2% | +$4.97K | 1.21% | 28 |
|
|
2016
Q1 | $2.07M | Buy |
13,817
+305
| +2% | +$45.3K | 1.24% | 26 |
|
|
2015
Q4 | $2.19M | Hold |
13,512
| – | – | 1.36% | 24 |
|
|
2015
Q3 | $1.87M | Sell |
13,512
-999
| -7% | -$157K | 1.21% | 30 |
|
|
2015
Q2 | $2.47M | Sell |
14,511
-978
| -6% | -$157K | 1.45% | 25 |
|
|
2015
Q1 | $2.48M | Sell |
15,489
-101
| -0.6% | -$15.9K | 1.39% | 27 |
|
|
2014
Q4 | $2.48M | Sell |
15,590
-1,000
| -6% | -$156K | 1.35% | 27 |
|
|
2014
Q3 | $2.33M | Buy |
16,590
+197
| +1% | +$25.7K | 1.24% | 28 |
|
|
2014
Q2 | $1.94M | Buy |
16,393
+1,825
| +13% | +$211K | 1.04% | 35 |
|
|
2014
Q1 | $1.8M | Hold |
14,568
| – | – | 1.03% | 38 |
|
|
2013
Q4 | $1.66M | Hold |
14,568
| – | – | 0.97% | 40 |
|
|
2013
Q3 | $1.63M | Buy |
14,568
+400
| +3% | +$43.4K | 1.06% | 36 |
|
|
2013
Q2 | $1.4M | Buy |
+14,168
| New | +$1.47M | 0.94% | 40 |
|
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Aull & Monroe Investment Management's AMGN Position: Q2 2026 in Review
Aull & Monroe Investment Management increased its Amgen (AMGN) stake by 0.53% in Q2 2026, buying an estimated $17.1K and bringing the position to 9,494 shares worth $3.44M. The position accounts for 1.44% of the portfolio, ranked #22.
Aull & Monroe Investment Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.58M in Q4 2023. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Aull & Monroe Investment Management held 9,494 shares of Amgen worth $3.44M as of Q2 2026.
- Aull & Monroe Investment Management bought 50 Amgen shares in Q2 2026, an estimated $17.1K.
- Amgen made up 1.44% of Aull & Monroe Investment Management's portfolio in Q2 2026, its #22 holding.
- Aull & Monroe Investment Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- Aull & Monroe Investment Management's Amgen position peaked at $3.58M in Q4 2023.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Aull & Monroe Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.